Huperzine A for mild cognitive impairment

Author:

Yue Jirong1,Dong Bi Rong1,Lin Xiufang1,Yang Ming1,Wu Hong Mei1,Wu Taixiang2

Affiliation:

1. West China Hospital, Sichuan University; Department of Geriatrics; No. 37, Guo Xue Xiang Chengdu Sichuan China 610041

2. West China Hospital, Sichuan University; Chinese Clinical Trial Registry, Chinese Ethics Committee of Registering Clinical Trials; No. 37, Guo Xue Xiang Chengdu Sichuan China 610041

Publisher

Wiley

Subject

Pharmacology (medical)

Reference61 articles.

1. Effectiveness of huperzine A in the treatment of mild cognitive impairment;Cheng;Strait Pharmaceutical Journal,2008

2. Ding S-J Ni Y-H Li J-S Effectiveness of huperzine A, nimodipine and the combinative utilization to age associated memory impairment and influence of those to levels of plasma total antioxidant capacity and calcium of platelet [in Chinese] Journal of Clinical Neurology 2009 130 2

3. Research of the patients with vascular cognitive impairment no dementia in terms of neuropsychology and the clinical study of huperzine A in the treatment;Jiang;Chinese Journal of Clinical Neurosciences,2009

4. Preliminary analysis of huperzine A tablets for treatment of mild cognitive impairment in community;Lin;Chinese Journal of Integrative Medicine on Cardio-/Cerebrovascular Disease,2008

5. Ma YX Zhu Y Gu YD Yu ZY Yu SM Ye YZ Double-blind trial of huperzine-A (Hup) on cognitive impairment and dementia in 314 cases Naunyn-Schmiedebergs Archives of Pharmacology 1998 P35194

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3